Plasma PAI-1 levels and factor V activity were increased in diabetic patients with microvascular complications and plasma PAI-1 levels and factor VII activity were significantly higher in diabetic patients with nephropathy than in diabetic patients without nephropathy [35]. This evidence concerns the gene SERPINE1 and complication.